Mary Ann Gray, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 4,250 shares at $35.00 ($149K) on 2015-01-13, disclosed to the SEC on 2015-01-15.
Scheduled sale ($149k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2013-08-28 | $310K | — | Filing → |
| GTCB | BUY | 2007-12-17 | $9K | — | Filing → |
| DYAX | BUY | 2006-05-19 | $29K | — | Filing → |